90
Participants
Start Date
September 16, 2020
Primary Completion Date
May 31, 2026
Study Completion Date
May 31, 2026
Loss frame sleep extension intervention
Aim 2 will be an interventional study design utilizing Fitbit and text messaging to perform a loss-framed incentive intervention designed to motivate participants to increase their sleep duration. Glycemic control will be measured via laboratory testing of hemoglobin A1c and Libre continuous glucose monitoring (CGM) for 2 weeks pre- and post-intervention. A focus group will be conducted prior to this intervention with patients ineligible for the intervention in order to determine appropriate text messaging.
RECRUITING
Children's Hospital of Philadelphia, Philadelphia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Children's Hospital of Philadelphia
OTHER